Highnoon Laboratories (KAR:HINOON) Marketable Securities: ₨3,477 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KAR:HINOON Highnoon Laboratories Ltd KAR:HINOON
96 GF Score
Price ₨934.86
GF Value ₨1,038.74
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Highnoon Laboratories Marketable Securities?

Highnoon Laboratories KAR:HINOON -1.64% 96 Marketable Securities is ₨3,477 Mil as of Mar. 2026. GuruFocus rates KAR:HINOON with a GF Score™ of 96/100 and a GF Value™ of ₨1,038.74 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Highnoon Laboratories's Marketable Securities for the quarter that ended in Mar. 2026 was ₨3,477 Mil.

Highnoon Laboratories's annual Marketable Securities increased from Dec. 2023 (₨2,169 Mil) to Dec. 2024 (₨3,639 Mil) but then declined from Dec. 2024 (₨3,639 Mil) to Dec. 2025 (₨3,060 Mil).

Highnoon Laboratories  (KAR:HINOON) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Highnoon Laboratories Marketable Securities Related Terms

Highnoon Laboratories Marketable Securities Historical Data

* Premium members only.

The historical data trend for Highnoon Laboratories's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Highnoon Laboratories Marketable Securities Chart

Highnoon Laboratories Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,059.74 1,338.89 2,168.79 3,638.85 3,059.62

Highnoon Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,619.08 1,698.96 1,368.33 3,059.62 3,476.87
KAR:HINOON
96GF Score
Highnoon Laboratories Ltd KAR:HINOON
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Highnoon Laboratories Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₨3,477 Mil mean?
Highnoon Laboratories (KAR:HINOON) has a Marketable Securities of ₨3,477 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Highnoon Laboratories and its competitors.
Is Highnoon Laboratories' Marketable Securities too high?
Highnoon Laboratories' current Marketable Securities is ₨3,477 Mil. Overall, Highnoon Laboratories has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Highnoon Laboratories' Marketable Securities compare to LLY and JNJ?
Highnoon Laboratories' Marketable Securities of ₨3,477 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Drug Manufacturers company?
A good Marketable Securities depends on the Drug Manufacturers industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Highnoon Laboratories and its competitors. Highnoon Laboratories's current Marketable Securities is ₨3,477 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Highnoon Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Highnoon Laboratories (KAR:HINOON) is currently considered Modestly Undervalued. The stock's GF Value™ is ₨1,038.74, compared to a current price of ₨934.86 — trading 10% below its estimated fair value. The current Marketable Securities is ₨3,477 Mil. Highnoon Laboratories' overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Highnoon Laboratories (KAR:HINOON), the current Marketable Securities is ₨3,477 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Highnoon Laboratories (KAR:HINOON) Overvalued in 2026?

Based on GuruFocus' analysis, Highnoon Laboratories stock appears to be undervalued. The current stock price of ₨934.86 is trading 10% below its estimated GF Value™ of ₨1,038.74. GuruFocus considers Highnoon Laboratories to be Modestly Undervalued.

Key valuation signals for KAR:HINOON:

  • Marketable Securities: ₨3,477 Mil
  • GF Value™: ₨1,038.74 vs. price of ₨934.86 (10% below fair value)
  • GF Score™: 96/100 with 3 warning signs

No single metric tells the full story. See the KAR:HINOON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Highnoon Laboratories Business Description

Address Jail Road, 901-9th floor, Tricon Corporate Center 73-E, Lahore, PAK
Highnoon Laboratories Ltd is a company engaged in the manufacture, import, sale, and marketing of pharmaceutical and allied consumer products. It focuses on the alimentary tract and metabolism, antihistamines, anti-infectives, cardiovascular, endocrine, hematology, musculoskeletal, nervous system, parasitology, respiratory, and urinary. Its products include AIRTAL (Aceclofenac); ARIA (ketotifen); ARTECXCIN, and artrodar (diacerein). Its other products include Asthavent, AXESOME, Bezisox, Betatec, and many more.
96GF Score

Get the complete analysis for KAR:HINOON

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨934.86
Price
₨1,038.74
GF Value